Bristol-Myers Squibb Co vs IAC/Interactivecorp — how do they compare? Bristol-Myers Squibb Co trades at $63.7 (market cap $129.94B), while IAC/Interactivecorp trades at $40.11 (market cap $2.97B). The key difference: Bristol-Myers Squibb Co is far larger — about 43.8× IAC/Interactivecorp's market cap, and Bristol-Myers Squibb Co pays a 3.96% dividend while IAC/Interactivecorp pays none. Which is the better fit depends on your goals.
| BMY | PPLI | |
|---|---|---|
Market Cap | $129.94B | $2.97B |
Sector | Health | Media |
52-Week High | $65.89 | $47.62 |
52-Week Low | $42.60 | $31.52 |
Enterprise Value | $163.92B | $3.28B |
Dividend Yield | 3.96% | — |
Trailing returns across standard periods
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →IAC Inc is an Internet media company with segments that include Angi (47% of total revenue), Dotdash (10%), search (24%), and emerging and other (19%). The firm spun off the narrow-moat dating app provider Match Group in second-quarter 2020 and the no-moat video software provider Vimeo in second-quarter 2021.
Read more on PPLI →